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Sumoylation is a reversible posttranslational modifi-
cation that plays roles in many processes, including
transcriptional regulation, cell division, chromosome
integrity, and DNAdamage response. Using a proteo-
mics approach, we identified 250 candidate targets
of sumoylation in C. elegans. One such target is the
cytoplasmic intermediatefilament (cIF)proteinnamed
IFB-1, which is expressed in hemidesmosome-like
structures in the worm epidermis and is essential for
embryonic elongation and maintenance of muscle
attachment to the cuticle. In the absence of SUMO,
IFB-1 formed ectopic filaments and protein aggre-
gates in the lateral epidermis. Moreover, depletion of
SUMO or mutation of the SUMO acceptor site on
IFB-1 resulted in a reductionof its cytoplasmicsoluble
pool, leading to a decrease in its exchange rate within
epidermal attachment structures. Theseobservations
indicate that SUMO regulates cIF assembly by main-
taining a cytoplasmic pool of nonpolymerized IFB-1,
and that this is necessary for normal IFB-1 function.
INTRODUCTION
SUMO, a small ubiquitin-like modifier, is attached covalently to
target proteins via a series of enzymatic reactions carried out
by SUMO-specific enzymes (Melchior, 2000). This posttransla-
tional modification is essential for normal development and
viability because it regulates a variety of essential biological
processes, such as the cell cycle, apoptosis, chromatin integrity,
and nucleocytoplasmic transport. Modification by SUMO serves
as a signal for changing protein interactions that may modify
substrate activity, localization, and stability (Geiss-Friedlander
andMelchior, 2007; Johnson, 2004;Melchior, 2000). Novel inter-
actions between a SUMO-modified substrate and additional
proteins can be mediated through a SUMO interaction motif
(SIM) domain (Song et al., 2004).
The majority of the known targets of SUMO in yeast and
mammalian cells are nuclear proteins, including transcription
factors, chromatin-associated proteins, DNA repair proteins,724 Developmental Cell 17, 724–735, November 17, 2009 ª2009 Elsand components of the PML (promyelocytic leukemia) nuclear
bodies (Gill, 2005;Hay, 2005;Seeler andDejean, 2003).However,
SUMO also modifies substrates in the cytoplasm, mitochondria,
plasma, and ER membrane (Geiss-Friedlander and Melchior,
2007). Some of the first identified substrates for SUMO were
the S. cerevisiae septins (Johnson and Blobel, 1999; Takahashi
et al., 1999). Septins are cytoskeletal proteins which form a belt
of 10 nmfilaments that encircles thebudneck.Mutagenesis anal-
ysis suggests that sumoylationof septins is required for thedisas-
sembly of the ring during cytokinesis (Johnson andBlobel, 1999).
SUMO proteins are highly conserved through evolution. Inver-
tebrates have a single SUMO protein while mammalian cells
ubiquitously express three SUMO paralogs (SUMO-1, SUMO-
2, and SUMO-3) (Johnson, 2004). The C. elegans genome
encodes for one SUMO gene, called smo-1, which is required
for embryonic and postembryonic development (Broday et al.,
2004; Jones et al., 2002). To further elucidate the role of
SUMO in a multicellular organism, we have performed a proteo-
mics screen designed to identify a wide range of proteins modi-
fied by sumoylation in C. elegans. Among the putative targets is
a group of cytoplasmic and nuclear intermediate filament
proteins. We focused on IFB-1, a protein that belongs to the
cytoplasmic intermediate filament (cIF) family (Karabinos et al.,
2001, 2003; Woo et al., 2004). cIFs assemble into 10 nm filament
networks that provide cells with mechanical integrity (Herrmann
and Aebi, 2004). In addition, cIFs were shown to play an impor-
tant role in signaling platforms that sense stress, regulate
organelle function, and are involved in cell migration (Kim and
Coulombe, 2007). The assembly of mature filaments was eluci-
dated in vitro, but the polymerization process and IF assembly
in cells remains largely unknown. In vertebrates cIFs form a large
multigene family of about 70 members, whereas the C. elegans
genome contains 11 cIF genes (Karabinos et al., 2001). A subset
of worm cIF proteins function in epidermal attachment structures
that are structurally related to vertebrate hemidesmosomes and
are required forC. elegans epidermal mechanical strength (Chis-
holm and Hardin, 2005; Fridkin et al., 2004). IFB-1 and additional
cIFs are also essential for embryonic epidermal morphogenesis
at the stage of embryonic elongation (Chisholm and Hardin,
2005). Here we demonstrate that IFB-1 is sumoylated at the
C terminus and that SUMO regulates its assembly into the
epidermal filaments, likely by serving as an IFB-1-sequestering
protein.evier Inc.
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Identification of SUMO Targets in C. elegans
To identify new substrates of the SUMO pathway in a multicellular
organism, we constructed aC. elegans strain that expresses His6-
and Flag-tagged SMO-1/SUMO as its only copy of the SUMO
gene. SUMO-conjugated proteins were isolated from this strain
by a double-affinity purification procedure, and components of
the isolated protein mixture were then identified by subsequent
LC-MS/MS analysis (see Figure S1 available online) (Denison
et al., 2005a, 2005b). Using a mixed population of worms, we ex-
pected to identify targets from all developmental stages and
tissues because SUMO is widely expressed inC. elegans (Broday
et al., 2004). Candidate proteins were grouped according to
molecular function and biological process (Figure 1; Table S1).
The large variety of targets demonstrated the global role of
SUMO modification in the regulation of many cellular processes.
In addition to the expected high fraction of nuclear proteins, we
identified a large group of cytosolic, membrane, and other subcel-
lular organelle proteins, as have been found in similar proteomics
studies in yeast, mammalian cells, and Drosophila (Ganesan
et al., 2007;Makhnevych et al., 2009; Nie et al., 2009; Panse et al.,
2004; Rosas-Acosta et al., 2005; Wohlschlegel et al., 2004). Puta-
tive targets of note from the newly identified nonnuclear proteins
are involved in posttranslational modifications such as phosphor-
ylation, glycosylation, and myristoylation (in addition to known
targets such as enzymes of the SUMO and ubiquitin pathways
and proteosomal subunits). This highlights possible crosstalk
between sumoylation and various posttranslational modification
pathways, as has already been shown for ubiquitin (reviewed in
Perry et al., 2008). Additional identified targets in this screen are
cytoskeleton components that include actin-binding proteins,
myosins, a- and b-tubulin, and intermediate filament proteins
(TableS1). IFB-1 isacIFprotein that is required forembryonicelon-
gation and formaintenance of themechanical linkage between the
muscle and cuticle. The ifb-1 locus encodes two isoforms, IFB-1A
and IFB-1B (Woo et al., 2004). We focus here on IFB-1A (hereafter
referred to as IFB-1) and show that SUMOmodification is required
for its regulated assembly and function in the epidermal attach-
ment structures.
Figure 1. SUMO Putative Targets in C. ele-
gans
The identified SUMOputative targets are arranged
in functional groups according to their relative
abundance. Nuclear targets are labeled with blue
colors. Cytoskeleton targets are labeled in red.
The entire list of candidates is presented in Table
S1. See also Figure S1.
Deletion of the smo-1Gene Causes
Collapse of the Normal IFB-1
Pattern and Formation of Ectopic
Filaments and Cytoplasmic
Inclusions
To elucidate the function of IFB-1 sumoy-
lation, we analyzed its localization pattern
in wild-type and smo-1 null worms. Im-
munostaining with anti-IFB-1 antibody
and analysis of IFB-1::GFP reporter in wild-type animals showed
that IFB-1 is localized at the basal and apical membrane of the
epidermis in a pattern of circumferential stripes (Figures 2A,
2C, and 2E) (Woo et al., 2004), consistent with its localization
in hemidesmosome-like structures (reviewed in Cox and Hardin,
2004). Homozygous smo-1(ok359) progeny (ok359 is a deletion
allele of the smo-1 gene) of heterozygous mothers are viable
due to maternally supplied SUMO product, but develop into
sterile adults with aberrant somatic gonad, germ line, and vulva,
probably as a result of dilution/degradation of the maternal smo-
1 gene product during larval development (Broday et al., 2004).
In such smo-1 homozygous mutants derived from heterozygous
parents, the normal pattern of IFB-1 was disrupted and ectopic
cytoplasmic filamentous structures, mainly circular and long fila-
ments, were observed in the lateral epidermis (Figures 2B, 2D,
and 2F–2H, short and long arrows). In addition, IFB-1 accumu-
lated in two types of cytoplasmic inclusions. The first type of
inclusion appeared as enlarged ‘‘nucleation sites’’ of the poly-
merizing filaments in the ventral and dorsal epidermis. These
inclusions were arranged in linear arrays and were restricted to
the region of the normal attachments (Figures 2B, 2D, and 2F,
bracket). The second type of inclusion was scattered throughout
the cytoplasm in the lateral epidermis (Figures 2B, 2D, 2H, and
2I, arrowhead). Analysis of the IFB-1::GFP reporter showed
increasing accumulation of these inclusions during incremental
developmental stages in smo-1(ok359) worms (Figures 2F–2I).
At the early L4 stage, there were mainly circular structures
(Figure 2F, short arrow), whereas at the mid-L4 stage when the
maternal product is thought to be depleted (Broday et al.,
2004) additional long filaments (Figure 2G, long arrow) appeared
in the lateral epidermis. By the late L4 stage large inclusions
became visible (Figure 2H, arrowhead) and the apical and basal
stripes were disorganized (Figure 2H, inset). In adults there were
mainly GFP inclusions and abnormal weakly fluorescent apical
and basal stripes (Figure 2I). To characterize the dynamics of
the IFB-1::GFP molecules within the inclusions, we performed
fluorescence recovery after photobleaching (FRAP) analysis.
Two main groups of inclusions were identified, inclusions that
exhibit no recovery of fluorescence (10 min postphotobleach-
ing), suggesting that they contain nondiffusing insolubleDevelopmental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc. 725
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the mobility of molecules from the nonbleached region of the
inclusion, and probably contain a larger fraction of soluble
IFB-1::GFP (Figure S2). Accordingly, using a complementary
fluorescence loss in photobleaching (FLIP) analysis, loss of fluo-
rescence was detected in some of the inclusions and in all the
intermediate circular structures (Figure S2). Indeed, the inclu-
sions that contained soluble IFB-1::GFP species showed mainly
internal recovery in FRAP, but FLIP analysis showed loss of fluo-
rescence, indicating that these inclusions are not membrane en-
closed. This limited recovery provides evidence of a lack of
a cytosolic pool of IFB-1::GFP subunits in the smo-1(ok359)
epidermis (see below). We next compared the localization of
IFB-1 in smo-1(ok359) worms to its overexpression in a wild-
type background using transgenic worms expressing hsp-
16p::IFB-1::His6 (Figure S2). The exogenously expressed protein
colocalized with the endogenous IFB-1, and when high levels of
transgene were expressed, we observed formation of IFB-1
inclusions that were restricted to the basal and apical side of
the hemidesmosome-like plaques andwere therefore suggested
to be enlarged ‘‘nucleation sites.’’ A few small aggregates were
observed in the lateral epidermis, similar to aggregates previ-
ously reportedwithGFP-taggedcIFsandsuggested tobea result
of overexpression (Hapiak et al., 2003; Woo et al., 2004). Thus,
overexpression of IFB-1 in the presence of SUMO in wild-type
worms did not mimic the formation of ectopic inclusions and
cytoplasmic filamentous structures in the lateral epidermis which
had been detected in the smo-1mutant worms (Figure 2).
Other Hemidesmosome-like Components
Are Disrupted in smo-1 Mutant Worms
To determine whether additional cIFs are affected by SUMO, we
used the MH4 antibody (Francis and Waterston, 1991), which
recognizes IFA-1, -2, and -3. IFA-2, also known as MUA-6 (Ha-
piak et al., 2003) (Figure 3A), was identified among the putative
targets in our screen (Table S1) and has been shown to hetero-
polymerize with IFB-1 in vitro (Karabinos et al., 2003). In addition
to disorganized apical and basal stripes, we observed abnormal
circular filaments similar to the IFB-1 circular structures (Fig-
ure 3B). It is possible that these circular filaments resulted from
nonsumoylated IFAs or that the association between IFB-1 and
Figure 2. Abnormal IFB-1 Filaments and Formation of Inclusions in
smo-1-Deleted Worms
Localization of IFB-1 in wild-type and smo-1(ok359) mutant.
(A–D) Immunostaining with anti-IFB-1 antibody at the late L4 stage. (A and C)
IFB-1 localization in the epidermal circumferential bands in wild-type is shown.
There is no staining in the lateral epidermis (indicated by asterisk). (B and D)
IFB-1 accumulates in the smo-1(ok359) worms in a linear array of inclusions
(bracket), lateral inclusions (arrowhead), long filaments (long arrow), and
abnormal circular filaments (short arrow).
(E–I) Localization of IFB-1::GFP in wild-type and smo-1(ok359) mutants. (E) In
the L4 wild-type larva, expression is restricted to circumferential bands in the
dorsal and ventral epidermis. The arranged parallel bands are shown in the
inset. (F–I) IFB-1::GFP expression in smo-1(ok359) mutant is shown: (F) early
L4, circular filaments in the lateral epidermis (short arrow); (G) mid L4, long fila-
mentous (long arrow) and circular structures (short arrow); (H) late L4, GFP
inclusions (arrowhead), dorsal and ventral epidermal attachments (inset); (I)
adult, GFP inclusions (arrowhead). Bar: 20 mm in (A) and (B), 10 mm in (C)–(I).
See also Figure S2.726 Developmental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc.
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mutant worms that accumulate abnormal IFB-1.
To determine whether other components of the transepider-
mal attachments exhibit similar abnormalities, we analyzed the
expression pattern of myotactin and VAB-19/Kank (Figures
3C–3F). Myotactin is a transmembrane adhesion molecule at
the basal side of the epidermis and is predicted to link VAB-
10A/plectin and cIFs (Bosher et al., 2003; Hresko et al., 1999;
Plenefisch et al., 2000). VAB-19/Kank is a cytoplasmic adaptor
protein that is localized to both the apical and basal attachments
(Ding et al., 2003). Both components are required for mainte-
nance of the hemidesomosome-like attachments. The staining
pattern of both proteins, but especially of VAB-19, in smo-
1(ok359)worms exhibited disorganization of the annular arrange-
ment (Figures 3D and 3F). Short linear arrays of VAB-19::GFP
inclusions were observed in the apical or basal hemidesmo-
some-like structures (Figure 3F, bracket). A few small aggregates
of myotactin visualized with the MH46 antibody (Francis and
Waterston, 1991) were observed in the lateral epidermis
(Figure 3D, circle). The disorganized pattern of the circumferen-
tial stripes of VAB-19::GFP in the smo-1 deletion mutant resem-
bled the IFB-1::GFP arrangement in smo-1 worms (Figure 3F
compared to Figure 2H, insets), suggesting that VAB-19 localiza-
tion in the hemidesmosome-like attachments depends onnormal
sumoylation of cIFs. We failed to observe circular filaments or
large inclusions for either myotactin or VAB-19. In addition, we
did not detect a muscle detachment (Mua) phenotype in smo-
1(ok359) worms, which has been observed in mytoactin and
VAB-19mutants, suggesting that although the attachment struc-
tures are disorganized they are still functional.
Figure 3. Additional Components of the
Hemidesmosome-like Attachments Do Not
Accumulate into Large Inclusions
(A and B) Staining of wild-type and smo-1(ok359)
mutant with the MH4 antibody. (A) The wild-type
pattern of the MH4 antibody is similar to anti-
IFB-1. (B) Attachment structures in the smo-1
mutant (inset) are shown. Circular filaments are
labeled with a short arrow.
(C and D) Staining of wild-type and smo-1(ok359)
mutant with the MH46 antibody. Small inclusions
in the lateral epidermis are circled.
(E and F) VAB-19::GFP expression in wild-type
and smo-1(ok359) mutants. Brackets indicate
elongated inclusions at the ventral epidermis.
Asterisks indicate restriction of thewild-type stain-
ing to the dorsal and ventral epidermis. Bar: 10 mm.
SUMO Is Required for Cytoplasmic
Localization of IFB-1 and for
Embryonic Elongation
During embryonic elongation, formation
of the nascent hemidesmosome-like
structures enabled us to observe de
novo formation of the IF network. To
examine the effect of SUMO on IFB-1
localization and function during this
process, we used the feeding-RNAi
approach to deplete SUMO. We selected
for embryos that had enough SUMO to perform embryonic cell
divisions until the comma stage (early elongation). IFB-1 expres-
sion during embryonic elongation was followed using the IFB-1::
GFP reporter. Expression of IFB-1::GFP was initially detected
at the comma stage in the cytoplasm. At the 1.5-fold stage an
increased fluorescence signal was detected in the cytoplasm
and was localized to the dorsal and ventral epidermis (detected
in 34/35 embryos analyzed) (Figures 4A–4D, inset). This sug-
gested that a cytoplasmic pool of soluble IFB-1 is maintained
during the formation of the epidermal attachment plaques and
supplies building blocks that then incorporate into the nascent
structures during the process of embryonic elongation. At the
2-fold stage, the protein localized to the newly formed hemides-
mosome-like structures, and the complete pattern of circumfer-
ential bands is observed before hatching (Figures 4E–4H, inset).
Accumulation of small aggregates (Figures 4D and 4F circle)
could be a result of overexpression of the GFP reporter (Woo
et al., 2004) and storage of IFB-1 prior to its polymerization as
has been shown for type II keratins in mouse embryos (Lu
et al., 2005). Analysis of smo-1(RNAi) viable embryos revealed
an abnormal pattern of IFB-1 expression (Figures 4I–4P). As
soon as GFP fluorescence could be detected at the comma
stage and later, at 1.5-fold stage, IFB-1 was localized to
abnormal thick and short filamentous structures in all regions
of the epidermis (detected in 34/38 embryos analyzed) while
cytoplasmic staining was very weak or undetectable (32/38
embryos) (Figures 4I–4L, inset). We did not detect any normal
embryos beyond the 1.5-fold stage. Embryos were arrested
with severe elongation defects, although they did display muscle
twitching (Figures 4M–4P). These results suggest that duringDevelopmental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc. 727
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a soluble fraction that serves as storage for free subunits. These
subunits are then available for incorporation into the newly
assembled filaments. When SUMO is depleted, this pool is elim-
inated, leading to aberrant polymerization of IFB-1. Such altered
IFB-1 assembly could in turn result in the defective embryonic
elongation seen in smo-1(RNAi) embryos.
The Cytoplasmic-to-Filament Exchange Rate for IFB-1
Is 2-Fold Slower in smo-1 Mutant Animals
To test whether SUMO indeed maintains a cytoplasmic pool of
IFB-1 that is available for incorporation into the hemidesmo-
some-like structures, we measured the FRAP time course of the
IFB-1::GFP reporter in bothwild-typeand smo-1(ok359)epithelial
attachments. FRAP analysis of IFA-1::GFP and IFB-1::GFP has
been previously performed in the marginal cells of the pharynx,
showing slow recovery with kinetics on the order of hours (Kara-
binos et al., 2003). Similarly, the half-life recovery time (t1/2) of
keratins heteropolymers is 100 min, in contrast to a t1/2 of 6
min for vimentin homopolymers in cultured epithelial cells (Yoon
et al., 2001). As shown in typical images in Figure 4Q (and in
Movies S1 and S2), FRAP at the epithelial attachment sites
occurred more rapidly in the wild-type background than in the
smo-1mutantworms.The ratio of theaveragenormalizedfluores-
cence intensity (smo-1(ok359)/wt) approached 0.6 after about 20
min, indicating slower recovery of the smo-1 mutant (Figure 4R).
The average t1/2 was 54.9 min for IFB-1::GFP in wild-type fila-
ments and109.9min in the smo-1(ok359)background (Figure 4S).
These observations imply that the exchange rate between soluble
subunits and incorporated IFB-1 is slower when SUMO is
depleted, probably due to a decrease in the soluble pool of IFB-1.
IFB-1 Is Sumoylated on K460 in the C-Terminal
Immunoglobulin-Fold Domain
To determine whether IFB-1 is modified by SUMO and to map
the SUMO acceptor site(s), we first performed in vitro sumoyla-
tion reactions with wild-type IFB-1. Bacterially expressed IFB-1
was incubated with SUMO-1, the E1-activating SUMO enzyme
(SAE1 and SAE2), and Ubc9 in the presence of ATP. Western
blot analysis with a-IFB-1 antibodies detected a time-dependent
increase in the intensity of a slower migrating band with a molec-
ular-weight shift of about 20 kDa (themolecular weight of IFB-1 is
63.7 kDa) (Figure 5A, lanes 2–5). Higher molecular weight bands
that were observed following longer reaction periods may repre-
sent sumoylation at additional sites or formation of poly-SUMODevelopmchains on the primary site (Figure 5A, lanes 3–5). The slower
migrating bands were not seen when the E1 enzyme was absent
from the reaction (Figure 5A, lane 6). To identify the lysine(s)
required for sumoylation of IFB-1, site-directed mutagenesis
was carried out on each of the 12 lysine residues (mutated to
arginine) that are predicted to be sumoylated (SUMOsp algo-
rithm) (Xue et al., 2006) and/or are highly conserved (Figure 5B).
In vitro sumoylation assays were performed with single mutants
and/or mutant pairs, and possible changes in the degree of su-
moylation were monitored. This analysis identified K460, located
in the C-terminal Ig-fold domain of IFB-1, as the primary sumoy-
lation site. Instead of the clear sumoylation band at 83 kDa
(Figure 5C, upper arrow), two weaker bands above and below
this band were observed following in vitro sumoylation reactions
with the K460R mutant (Figure 5C, lane 8) as well as following
reactions with double or triple mutants that included K460R (Fig-
ure 5C, lanes 14–17). Although we can not rule out completely
the sumoylation, albeit at a very poor efficiency, on alternative
residues, it is noteworthy that these bands do not correspond
to the molecular change expected from the addition of one or
two SUMO molecules and likely represent background noise.
To further verify these results, deletion constructs in two regions
of IFB-1 that include several clustered predicted sumoylation
sites were assayed in vitro (Figure 5B): IFB-1D235-308, which
includes the 2a coil, linkers domains, and part of the 2b coil
(mid-helix), and IFB-1D433-506 in the tail domain (which
includes K460). Sumoylation reactions revealed that the IFB-
1D235-308 deletion construct is still sumoylated, whereas
sumoylation is abolished in IFB-1D433-506 (Figure 5D). These
results establish that sumoylation of IFB-1 takes place primarily
at its C-terminal tail.
To test whether IFB-1 is modified by SUMO in the animals, we
analyzed the functional fusion protein hsp-16::IFB-1::His6 and
hsp-16::IFB-1K460R::His6 (see below, Figure 6) in which the
SUMO acceptor site K460 was mutated to arginine. The two
constructs were expressed in transgenic worms under regula-
tion of the hsp-16 heat-shock promoter. Nickel-affinity purifica-
tion (Figure S3) of both wild-type andmutant IFB-1K460R extracts
from heat-shock-treated and control transgenic worms was
followed by western blotting using a-IFB-1 and a-SUMO anti-
bodies. A slower migrating form with a molecular weight shift
of about 20 kDa, consistent with SUMO-modified IFB-1, was de-
tected in extracts expressing wild-type IFB-1 (Figure 5E, lane 2).
This higher molecular weight band was abolished in the K460R
mutant, while increased IFB-1 levels following heat shock wasFigure 4. SUMO Is Required for a Cytoplasmic Mobile Pool of IFB-1
(A–H) DIC and expression pattern of IFB-1::GFP during elongation in wild-type embryos. (A and B) Cytoplasmic expression of IFB-1::GFP at the comma stage
(arrow). (C and D) Cytoplasmic expression at 1.5-fold stage (arrow, inset). Small aggregates are circled. (E and F) The transition from cytoplasmic to localized
expression in the nascent epidermal attachment sites at the 2-fold stage (box). (G and H) Fluorescence pattern of the circumferential bands of the mature
epidermal attachment structures at the 3.5-fold stage (inset).
(I–P) DIC and expression pattern of IFB-1::GFP of embryos from hermaphrodites treated with smo-1(RNAi). (I–L) Formation of abnormal filaments and no cyto-
plasmic staining at the comma stage and 1.5-fold embryos (inset). (M–P) Embryos with severe elongation defects at estimated parallel stages exhibit abnormal
pattern of filaments. Bar: 10 mm.
(Q–S) Depletion of SUMO decreases IFB-1 mobility measured by FRAP. (Q) Time-lapse micrographs of the bleached area before photobleaching (prebleach),
immediately after photobleaching (postbleach), and at intervals during recovery (min) of IFB-1::GFP reporter in wild-type and smo-1(ok359) animals. Bar:
5 mm. (R) Fluorescence intensities in the photobleached area are plotted against time. Values at each time point are normalized to a nonbleached area and to
the fluorescence ratios before the bleach. Analysis was performed to n = 12 worms from each genotype. (S) The half life time of fluorescence recovery, t1/2.
Mean values and standard deviations are shown. The differences between the t1/2 values of the wild-type (n = 12) and the smo-1(ok359) (n = 12) worms are statis-
tically significant (two sided t test, p < 0.0001). See also Movies S1 and S2.ental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc. 729
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lane 4). In both the wild-type and K460R, at least three bands
were detected below IFB-1 (upper blot, black dots) which are
likely to be a result of proteolytic cleavage of IFB-1, as has
been shown for several vertebrate IF proteins (Byun et al.,
2001; Ku and Omary, 2001). The results of this analysis indicate
that IFB-1 is a direct substrate for SUMO modification and that
K460 is the primary in vivo SUMO acceptor site of IFB-1.
The Sumoylation-Deficient K460R Protein Exhibits
a Reduced Cytoplasmic Pool of IFB-1
To test the hypothesis that sumoylation of IFB-1 is required for
maintenance of its cytoplasmic pool, we generated a fusion
protein, IFB-1K460R::GFP, expressed under the control of the
ifb-1 50 regulatory sequences. Relative to the wild-type IFB-1::
GFP reporter, we found a major reduction in cytoplasmic
expression of the mutant transgene during embryonic elonga-
tion, when filament assembly occurs. The mean fluorescence-
intensity ratio of cytoplasm to filament (cytoplasm values were
normalized to the fluorescence intensity in the nascent filaments;
see Experimental Procedures) was lower in the IFB-1K460R::GFP
worms than in thewild-type IFB-1::GFP strain (0.23 ± 0.09 versus
0.62 ± 0.11, respectively, p < 0.0001; Figures 5F and 5G). This
finding indicates that sumoylation of IFB-1 on K460 is required
to maintain its cytoplasmic pool during assembly of the
epidermal attachment structures. To further characterize the
Figure 5. IFB-1 Is Sumoylated In Vivo and
In Vitro on K460
(A) IFB-1 is modified by SUMO-1 in vitro. Re-
combinant IFB-1 was incubated for the indicated
times (minutes) in modification reactions including
E1 (SAE1 and SAE2), E2 (UBC9), SUMO-1, and
ATP (lanes 1–5) or control reaction without E1
(lanes 6, 60 min incubation).
(B) Schematic presentation of IFB-1 structure con-
sisting of head, rod, and tail domains. The four rod
subdomains (coils 1a, 1b, 2a, and 2b) are joined by
three nonhelical linkers (L1, L12, and L2). Lysine
residues predicted to be sumoylated (SUMOsp
algorithm) are underlined in blue (the four lysines
with the highest score are labeled with double
line), conserved lysines in worm and/or human IFs
areunderlined inblack, lysines included in the region
of the deletions are in black, and the lysines muta-
genized in this work are in red. The primary sumoy-
lation site, K460, is boxed. The IFB-1D235-308 and
IFB-1D433-506 deletion constructs are marked.
(C) In vitro sumoylation of wild-type and lysine-to-
arginine mutant forms of IFB-1. Shown are single
mutants (lanes 3–5, 7–13), double mutants (lanes
6, 14–16), or a triple mutant (lane 17). The sumoy-
lated-IFB-1 band is marked by an arrowhead.
(D) In vitro sumoylationofwild-typeand IFB-1D235-
308 (blue) and IFB-1D433-506 (purple) deletion
constructs. Reactions were performed with (+) or
without () E1 enzyme. Proteins were detected by
immunoblotting with anti-IFB-1-specific antibody.
(E) IFB-1 is sumoylated in C. elegans. Transgenic
worms expressing His6-tagged IFB-1 (Ishsp-16::
IFB-1::His) (lanes 1–2) or K460R mutant (Ishsp-
16::IFB-1K460R::His) (lanes 3–4) were treated with
heat shock (+) to induce IFB-1 expression, or
were nontreated controls (). Lysates (2mg total
protein) were subjected to affinity chromatography
on Ni-NTA agarose followed by immunoblotting
with anti-IFB-1 (upper panel) and anti-SUMO
(lower panel) specific antibodies. The sumoy-
lated-IFB-1 band is marked by an arrowhead.
Possible proteolytic forms of the induced IFB-1
are labeled with black dots. The levels of actin
and IFB-1 in total worm lysates (5% lysate) are
shown in the lower panels (Extracts); the two IFB-1
isoforms (1A and 1B) are labeled.
(F and G) Reduced cytoplasmic pool in IFB-1K460R::GFP embryos. Fluorescence intensity in the cytoplasm was measured in the dorsal or ventral epidermis of
1.5-fold embryos expressing the IFB-1::GFP (n = 32) or IFB-1K460R::GFP (n = 28) reporters. (F) Representative DIC and fluorescence images. (G) Fluorescence
intensity ratios. Values in the cytoplasm (yellow box) are normalized to the intensity values in the nascent epidermal attachment structures (white box). Mean
values and standard deviations are shown. The differences between the values of the IFB-1::GFP and the IFB-1K460R::GFP worms are statistically significant
(two sided t test, p < 0.0001). See also Figures S3 and S4 and Movie S3.730 Developmental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc.
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SUMO Regulates Cytoplasmic Intermediate Filamentssumoylation mutant form of IFB-1, we performed FRAP analysis
on the IFB-1K460R::GFP filaments. The exchange rate between
soluble and incorporated IFB-1 subunits was slower in IFB-
1K460R::GFP than in the wild-type IFB-1::GFP. The average t1/2
was 229 ± 138 min in the IFB-1K460R::GFP filaments (Figure S4)
compared to 54.9 ± 13.6 min in the IFB-1::GFP filaments (Fig-
ure 4S), both measured in a wild-type genetic background
(statistically significant difference; two-sided t test, p < 0.0001).
We conclude that the soluble pool of IFB-1K460R::GFP is smaller
than that of the wild-type IFB-1::GFP. In agreement with these
observations, the structure of the epidermal attachment sites
in larvae expressing IFB-1K460R::GFP was impaired (Figure S4)
and resembled the aberrant structures in the smo-1(ok359)
background (Figure 2).
K460 Is Required for IFB-1 Function during
Embryogenesis
The ifb-1(ju71) deletion allele causes abnormal embryonic elon-
gation, which results in incompletely penetrant embryonic arrest
at the 3-fold stage, as well as an abnormal head epidermis (the
Vab phenotype) (Woo et al., 2004) (Figures 6A and 6B). The
His-tagged wild-type IFB-1 protein expressed from the hsp-
16::IFB-1::His6 construct complemented the ifb-1(ju71) mutant
phenotype and was recognized by the a-IFB-1 antibody in the
apical and basal epidermis of ifb-1(ju71) embryos (Figures 6C,
6F, and 6G; Table S2). We assessed the functional activity of
the IFB-1K460R mutant protein expressed from the hsp-16::IFB-
1K460R::His6 construct by similar rescue experiments of the ifb-
1(ju71) embryos. Strikingly, the degree of rescue achieved by
the K460R mutant was limited to 26.6%, whereas the wild-type
IFB-1 or a control K498R mutant efficiently rescued (77.9%
and 67.9%, respectively) the ifb-1(ju71)mutant embryos (Figures
6C–6E; Table S2). Further analysis by immunostaining revealed
accumulation of abnormal discontinuous attachments and
ectopic inclusions in embryos expressing the K460R sumoyla-
tion mutant, but not in those expressing the wild-type IFB-1
protein (Figures 6F–6I). We conclude that abnormal, probably
nonfunctional attachments, combined with accumulation of
inclusions in the lateral epidermis (which are probably toxic at
this stage), prevent normal elongation.
DISCUSSION
The role of SUMO in multicellular organisms is still unclear. Here
we used a proteomics approach to identify diverse targets of
SUMO in C. elegans. Among the identified targets are cyto-
plasmic intermediate filament proteins. We chose to study IFB-
1, amember of the cIF family that links the apical and basal hemi-
desmosome-like structures of the epidermis. IFB-1 is sumoy-
lated on lysine 460, which is located at the Ig-fold domain at
the C-terminal tail of IFB-1. In vertebrates, this domain is found
only in nuclear lamins (Dhe-Paganon et al., 2002; Krimm et al.,
2002), while in C. elegnas it is found in both lamin and the cyto-
plasmic intermediate filament proteins (Karabinos et al., 2001).
This motif is known to be involved in protein-protein interactions
and is associated with 26% of the known mutations in lamins
causing laminopathies (Shumaker et al., 2008). It has been
shown to negatively regulate lamin polymerization (Shumaker
et al., 2005), which is in accordance with our suggested negative
regulatory role of SUMO in IFB-1 polymerization (Figure S5). Su-
moylation at the Ig-fold domain probably modulates the b sheet
structure and thus may transiently change protein interactions.
De novo assembly of cIFs takes place during embryonic elon-
gation. Depletion of SUMO at this stage of embryogenesis by
RNAi caused the formation of abnormal filaments and lack of
a cytoplasmic pool. At late larval stageswhenonly amaintenance
process of the existing network takes place, a low rate of
exchange of IFB-1 subunits within the existing filaments was de-
tected in smo-1(ok359) mutant animals compared to the wild-
type background in parallel to its accumulation into abnormal
filaments and cytoplasmic inclusions. Similar phenotypes were
observed when the sumoylation-deficient K460R protein was
analyzed in the wild-type background. Notably, although the
epidermal attachment sites of the IFB-1K460R::GFP larvae were
severely disorganized, no ectopic filaments or inclusions were
formed in their lateral epidermis, raising the possibility that
Figure 6. K460 Is Essential for IFB-1 Func-
tion during Embryonic Elongation
(A and B) Elongation of the epidermis in wild-type
and ifb-1(ju71) mutant embryos following heat
shock at gastrulation (control).
(C–E) Rescue experiments of the ifb-1(ju71)
embryos using heat-inducible transgenes ex-
pressing the wild-type IFB-1, IFB-1K498R, and
IFB-1K460R mutants (Table S2).
(F and G) Immunostaining of control () and
heat-shock-treated ifb-1(ju71);hsp-16::IFB-1::His
embryos (+). (H–I) immunostaining of control ()
and heat shock treated ifb-1(ju71);hsp-16::IFB-
1K460R::His embryos (+). Both endogenous and
ectopically expressed IFB-1 are detected by the
anti-IFB-1 antibody (red). Ectopically expressed
IFB-1 is detected by the anti-His antibody (green).
The box indicates the attachment structures in
dorsal epidermal cells. The arrow indicates
ectopic inclusions recognized by anti-IFB-1 and
anti-His antibodies. Bar: 10 mm.Developmental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc. 731
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prevent the formation of IFB-1 inclusions.
While abnormalities in the localization pattern were observed
in smo-1 mutant animals also for the epidermal attachment
components mytoactin and especially VAB-19, these proteins
did not display ectopic filaments and cytoplasmic inclusions.
This supports a specific role for SUMO in the regulation of cIFs
polymerization and suggests that abnormal cIF polymerization
affects the recruitment of additional components of the hemi-
desmosome-like attachments such as VAB-19.
The number of IFB-1 inclusions increases in smo-1-deleted
adult animals, suggesting complete depletion of the maternal
SUMO or overloading of the cellular degradation machinery.
The pathology of many IF-related diseases involves accumula-
tion of cytoplasmic inclusions, for example keratin-related liver
disorders that result in formation of Mallory bodies, (Nam-On
Ku et al., 2007) desmin-related myopathies (DRM) (Bar et al.,
2005), and GFAP mutants that are associated with Alexander
disease (Quinlan et al., 2007).
SUMO was found to accumulate in inclusions associated with
several neurodegenerative diseases, including multiple system
atrophy, Huntington’s disease, and other polyglutamine disor-
ders (Dorval and Fraser, 2007). On the other hand, our findings
show that lack of SUMO causes the formation of cIF aggregates.
Thus in different cellular environments, and in a target-specific
manner, SUMO can contribute to accumulation of protein aggre-
gates or protect against their formation. Indeed, recently it was
reported that the amyloid precursor protein (APP) is sumoylated
and that its sumoylation is associated with decreased levels of
Ab peptides (Zhang and Sarge, 2008b).
The assembly properties of cIFs have been studied in depth
in vitro (Herrmann and Aebi, 2004), but less is known about their
in vivo assembly. Regulation of cIF polymerization in vivo is
thought to be accomplished by posttranslational modifications.
cIFs are known to be heavily phosphorylated, mainly on the
N- and C termini (Omary et al., 2006). Reorganization of cIFs
during mitosis was shown to be phosphorylation dependent
(Chou et al., 1989). More recently it was demonstrated that
phosphorylation of keratins target them for degradation
through the ubiquitin-proteasome pathway in response to shear
stress (Jaitovich et al., 2008). Lower keratin ubiquitination andhy-
perphosphorylation are associated withMallory body deposits in
a variety of liver diseases (Ku and Omary, 2000). Sumoylation is
an additional posttranslational modification of cIFs that may be
involved in disease. Recently, human Lamin A, which is a nuclear
IF protein (the C. elegans Lamin, LMN-1 [Liu et al., 2000], was
identified as a candidate in this screen), was shown to be sumoy-
lated and its sumoylation associated with familial dilated cardio-
myopathy (Zhang and Sarge, 2008a).
Using a selective RNAi approach, we showed that the forma-
tion of abnormal filaments is accompanied by a major decrease
in cytoplasmic accumulation of IFB-1. These data suggest that
in vivo a soluble pool of cytoplasmic IFB-1 heterodimers (IFB-1
was shown to form heterotypic interaction with IFA proteins
in vitro [Karabinos et al., 2003]) or tetramers is maintained by
sumoylation. A regulated desumoylation process may be
responsible for the ability of the free subunits to polymerize
into tonofibrils (Figure S5). Thus, SUMO modification may serve
as an IFB-1-sequestering factor resembling the inhibitory mech-732 Developmental Cell 17, 724–735, November 17, 2009 ª2009 Eanism of actin assembly by Thymosin b4 (Hannappel, 2007).
Since the exchange rate between soluble subunits and polymer-
ized IFB-1::GFP in the epidermal attachment sites depends on
SUMO and on sumoylation of IFB-1, it supports such a role for
SUMO, probably by regulating the interactions with its associ-
ated proteins. In summary, we demonstrated here that SUMO
plays an important role in the process of cIF assembly by serving
as a negative regulator of filament assembly in vivo.
EXPERIMENTAL PROCEDURES
Strains
C. elegans was cultured as described (Brenner, 1974). The genes and alleles
used in this study are smo-1(ok359) (isolated and kindly provided by the C. el-
egans Gene Knockout Project team at Oklahoma Medical Research Founda-
tion [OMRF]) (Broday et al., 2004) and ifb-1(ju71) (Woo et al., 2004). In addition,
the following integrated transgenes or extrachromosomal arrays were used:
juIs176[IFB-1A::GFP; rol-6] (Woo et al., 2004), juIs167[VAB-19::GFP; rol-6]
(Ding et al., 2003), smo-1(ok359);tvEx25[psmo-1::His-FLAG-SMO-1; rol-6]
(this study), tvIs32[hsp-16::IFB-1::His] (this study), tvIs37[hsp-16::IFB-
1K460R::His] (this study), tvIs38[hsp-16::IFB-1K498R::His] (this study), and
tvIs41[IFB-1::GFP;rol-6] (this study), tvIs42[IFB-1K460R::GFP;rol-6] (this study).
Purification of SUMO Conjugates for Mass Spectrometry Analysis
For proteomics analysis the smo-1(ok359);tvEx25[psmo-1::His-FLAG-SMO-1;
rol-6] strain was constructed. The psmo-1::His-FLAG-SMO-1; rol-6 construct
contains the smo-1 genomic sequences and 50 and 30 regulatory sequences of
the smo-1 genomic region and rescues the smo-1 genetic deletion. The
rescued strain that expresses only the SUMO-tagged protein was used for
the proteomics analysis. Protein purification and mass spectrometry was
performed according to Denison et al. (2005b).
Antibodies
Antibodies used for western analysis were anti-SUMO (Zymed clone 21C7)
(1:1000), anti-IFB-1 (1:6000) (Karabinos et al., 2001), and anti-actin (Santa
Cruz) (1:1000). Antibodies used for immunofluorescencewere Penta-His Alexa
Fluor 488 conjugate (QIAGEN) (1:200), anti-IFB-1 (1:100), MH4 (1:10), and
MH46 (1:10).
In Vitro Sumoylation
Full-length ifb-1 cDNA was cloned in the pET-20b(+) vector (Novagen), ex-
pressed in BL21(DE3) bacteria at 30C, and purified with 8 M urea, 5 mM
Tris (pH 7.6), 1 mM ETDA, and 0.4 mM PMSF. Protein (0.2 mg/ml) was diluted
10 times in sumoylation buffer (103 buffer contains 200 mM HEPES [pH 7.5],
50 mMMgCl2, and 20mMATP) to allow formation of soluble oligomers. Reac-
tions were performed using in vitro SUMOylation kit purchased from LAE
Biotech International (Rockville, MD). Reactions were incubated at 37C at
the indicated time points. Reactions with IFB-1 mutants and control reactions
without E1 were incubated for 1 hr at 37C.
In Vivo Sumoylation
IFB-1 expression was induced by heat shock in transgenic worms harboring
the phsp16::IFB-1::His6 construct or phsp16::IFB-1
K460R::His6. The heat-
shock treatment was as following: 1 hr at 32C, 2 hr at 20C, 1 hr at 32C,
collection of worms and immediate freezing in liquid nitrogen. Protease inhib-
itor cocktail (sigma P1860) was added (1:500) after the first heat-shock treat-
ment. Transgenic wormswere lysed in 6M guanidinium-HCl, 0.1MNa2HPO4/
NaH2PO4 (pH 8.0), and 5 mM imidazole. Following sonication, lysates were
incubated for 4 hr with Ni-NTA beads and then washed and eluted according
to Treier et al. (1994) with an additional wash with 0.5% NP-40 before elution.
The eluted proteins were analyzed by anti-SUMO antibody and anti-IFB-1 anti-
body. Total worm lysate was TCA precipitated before gel electrophoresis and
analyzed by anti-actin and anti-IFB-1 antibodies.lsevier Inc.
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smo-1(RNAi) plasmid (clone 1013 from J. Ahringer RNAi library) or empty
L4440 vector were transformed into HT115 (DE3). RNAi by feeding was carried
out as described (Fraser et al., 2000). An overnight culture was diluted 1:100,
and at OD = 0.4 IPTG (Sigma Inc., cat. I5502) was added to a final concentra-
tion of 1 mM for 4 hr at 37C. The induced bacteria expressing smo-1 dsRNA
were then seeded directly onto NMG-RNAi plates containing 1 mM IPTG and
50 mg/ml carbenicillin. Seeded plates were dried at room temperature over-
night. Embryos expressing IsIFB-1::GFP (collected by bleaching of gravid
adults) were grown on RNAi plates at 20C for 4 days. For analysis of embryos,
adults were cut and the embryos were transferred to an agar pad for fluores-
cent and DIC examination.
Rescue Experiments of the ifb-1(ju71) Mutant and Immunostaining
of Embryos and L1 Larvae
The integrated strains Is[hsp-16::IFB-1::His], Is[hsp-16::IFB-1K460R::His], and
Is[hsp-16::IFB-1K498R::His] were crossed to the ifb-1(ju71) strain. Gravid
homozygous adults laid eggs for 2 hr and then were removed from plates.
Induction of IFB-1 was performed using the following conditions: 30 min at
32C, 2 hr at 20C 3 3. One heat shock for 30 min at 32C at late gastrulation
was sufficient to rescue embryos that harbor thewild-type IFB-1 construct. For
immunostaining, single induction was done by subjecting embryos (1.5 hr after
bleaching of gravid adults) to 30 min heat shock at 32C. Five inductions of
IFB-1 (Figure S2) were performed by subjecting embryos to 30min heat shock,
1.5 hr at 20C3 2, 30 min heat shock, 18 hr at 20C, 30 min heat shock, 1.5 hr
at 20C3 2 ,and fixation of L1 larvae for immunostaining. Fixation and staining
of embryos and L1 larvae were performed according to Finney (Finney and
Ruvkun, 1990).
Statistical Methods
Multiple repeats were performed in all experiments as indicated andmean and
standard deviation values were calculated. Hypothesis testing was performed
using a two-sided t test after rejecting the nonequal variance H1 assumption.
Error bars and error estimates (±) are the pertinent standard deviation values.
Microscopy and Quantification
Quantification of Cytoplasmic GFP in Embryos
To quantify the difference in cytoplasmic fluorescence between embryos, the
fluorescence intensity in the cytoplasm was normalized to the fluorescence
intensity of the nascent epidermal attachment sites in each embryo. Mean
values and standard deviation of normalized fluorescence intensity were
plotted for each strain. Analysis was performed with three independent strains
of each transgene in at least three independent experiments. Shown are
results from one representative strain.
FRAP Analysis of Filaments
Fluorescence recovery after photobleaching (FRAP) studies were performed
using a Zeiss LSM 5 EXCITER confocal scanning microscope. Worms at mid
L4 stage were mounted on 4% agarose pads and anesthetized with 0.1%
tricaine, 0.01% tetramisole 30 min before FRAP. Images were acquired (1%
laser power transmission) in a single z-plane using open pinhole at 1 min inter-
vals. Photobleaching was performed by 43 iterative scanning (100% trans-
mission) focused on a region of 6.86 mm2. Mean fluorescence intensity at
each time point within the bleached area and an adjacent unbleached region
was quantified using the LSM 5 EXCITER software following manual correc-
tions of the ROIs (due to animal movement).
Data Analysis
Normalized fluorescence intensity values were determined at each time point
by the ratio (Tt/Ct)/(T0/C0). T0 is the intensity in the ROI before photobleaching,
and Tt is the intensity in the ROI at a given time point after bleaching. C0 and Ct
are the intensities at time 0 and at time t, respectively, of a control unbleached
area (Brignull et al., 2006).
The variation with time of the normalized fluorescence intensity values was
averaged over n = 12 animals for each strain. In addition, for each movie the
normalized FRAP data was fitted to the equation 1  Aekt (Sprague and
McNally, 2005), where k is the estimated rate of binding, i.e., the rate of disso-
ciation-reassociation of the IFB-1::GFP molecules from and to the filament.
Specifically, the logarithm of the fraction of the fluorescence recovered wasDevelopmplotted against time, and the slope k was determined by linear regression for
each movie. Mean values and standard deviations of k were calculated for
n = 12 animals from each strain. The half life time of fluorescence recovery,
t1/2, representing the dissociation-reassociation kinetics of IFB-1::GFP to
the filaments, was calculated as t1/2 = ln 0.5/k.
FRAP Analysis of IFB-1 Inclusions
Images were acquired using open pinhole at 10 s intervals. Photobleaching
was performed by 63 iterative scanning (100% transmission) focused on
a region of 0.4 mm2.
FLIP Analysis of IFB-1 Inclusions
A region of 18 mm2 outside an inclusion was repeatedly bleached (13 scan-
ning) at 10 s intervals, and images were acquired using open pinhole following
each bleach. Measurements are shown for inclusions or circular-shaped
filaments located at a distance of 10 mm from the bleached area.
SUPPLEMENTAL DATA
Supplemental Data include five figures, three movies, two tables, and Supple-
mental Experimental Procedures. They are available at http://www.cell.com/
developmental-cell/supplemental/S1534-5807(09)00427-4/.
ACKNOWLEDGMENTS
We thank Rudolf Leube for the anti-IFB-1 antibody, Koret Hirschberg and
David Broday for consulting on FRAP analysis, and Ronen Zaidel-Bar for
comments on the manuscript. Some nematode strains used in this work
were provided by the Caenorhabditis Genetics Center, which is funded by
the NIH National Center for Research Resources (NCRR). The MH4 and
MH46monoclonal antibodies developed by theWaterston laboratory were ob-
tained from the Developmental Studies Hybridoma Bank developed under the
auspices of the NICHD and maintained by the Department of Biology, The
University of Iowa, Iowa City, IA. A.D.C. acknowledges funding from the NIH
(GM54657). This research was supported by grants from the Israel Science
Foundation (ISF 980/06) and the Israel Cancer Research Fund (06-203-
RCDA) to L.B. and National Institutes of Health (NIH) grant GM67945 to S.P.G.
Received: January 8, 2009
Revised: August 3, 2009
Accepted: October 8, 2009
Published: November 16, 2009
REFERENCES
Bar, H., Mucke, N., Kostareva, A., Sjoberg, G., Aebi, U., and Herrmann, H.
(2005). Severe muscle disease-causing desmin mutations interfere with
in vitro filament assembly at distinct stages. Proc. Natl. Acad. Sci. USA 102,
15099–15104.
Bosher, J.M., Hahn, B.S., Legouis, R., Sookhareea, S., Weimer, R.M., Gans-
muller, A., Chisholm, A.D., Rose, A.M., Bessereau, J.L., and Labouesse, M.
(2003). The Caenorhabditis elegans vab-10 spectraplakin isoforms protect
the epidermis against internal and external forces. J. Cell Biol. 161, 757–768.
Brenner, S. (1974). The genetics of Caenorhabditis elegans. Genetics 77,
71–94.
Brignull, H.R., Morley, J.F., Garcia, S.M., and Morimoto, R.I. (2006). Modeling
polyglutamine pathogenesis in C. elegans. Methods Enzymol. 412, 256–282.
Broday, L., Kolotuev, I., Didier, C., Bhoumik, A., Gupta, B.P., Sternberg, P.W.,
Podbilewicz, B., and Ronai, Z. (2004). The small ubiquitin-like modifier (SUMO)
is required for gonadal and uterine-vulval morphogenesis in Caenorhabditis
elegans. Genes Dev. 18, 2380–2391.
Byun, Y., Chen, F., Chang, R., Trivedi, M., Green, K.J., and Cryns, V.L. (2001).
Caspase cleavage of vimentin disrupts intermediate filaments and promotes
apoptosis. Cell Death Differ. 8, 443–450.
Chisholm, A.D., and Hardin, J. (2005). Epidermal morphogenesis. In Worm-
Book, The C. elegans Research Community, ed. doi/10.1895/worm-
book.1.35.1, http://www.wormbook.org.ental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc. 733
Developmental Cell
SUMO Regulates Cytoplasmic Intermediate FilamentsChou, Y.H., Rosevear, E., and Goldman, R.D. (1989). Phosphorylation and
disassembly of intermediate filaments in mitotic cells. Proc. Natl. Acad. Sci.
USA 86, 1885–1889.
Cox, E.A., and Hardin, J. (2004). Sticky worms: adhesion complexes in
C. elegans. J. Cell Sci. 117, 1885–1897.
Denison, C., Kirkpatrick, D.S., and Gygi, S.P. (2005a). Proteomic insights into
ubiquitin and ubiquitin-like proteins. Curr. Opin. Chem. Biol. 9, 69–75.
Denison, C., Rudner, A.D., Gerber, S.A., Bakalarski, C.E., Moazed, D., and
Gygi, S.P. (2005b). A proteomic strategy for gaining insights into protein
sumoylation in yeast. Mol. Cell. Proteomics 4, 246–254.
Dhe-Paganon, S., Werner, E.D., Chi, Y.-I., and Shoelson, S.E. (2002). Structure
of the globular tail of nuclear lamin. J. Biol. Chem. 277, 17381–17384.
Ding, M., Goncharov, A., Jin, Y., and Chisholm, A.D. (2003). C. elegans ankyrin
repeat protein VAB-19 is a component of epidermal attachment structures and
is essential for epidermal morphogenesis. Development 130, 5791–5801.
Dorval, V., and Fraser, P.E. (2007). SUMO on the road to neurodegeneration.
Biochim. Biophys. Acta 1773, 694–706.
Finney, M., and Ruvkun, G. (1990). The unc-86 gene product couples cell
lineage and cell identity in C. elegans. Cell 63, 895–905.
Francis, R., andWaterston, R.H. (1991). Muscle cell attachment inCaenorhab-
ditis elegans. J. Cell Biol. 114, 465–479.
Fraser, A.G., Kamath, R.S., Zipperlen, P., Martinez-Campos, M., Sohrmann,
M., and Ahringer, J. (2000). Functional genomic analysis ofC. elegans chromo-
some I by systematic RNA interference. Nature 408, 325–330.
Fridkin, A., Karabinos, A., and Gruenbaum, Y. (2004). Intermediate filaments in
Caenorhabditis elegans. Methods Cell Biol. 78, 703–718.
Ganesan, A.K., Kho, Y., Kim, S.C., Chen, Y., Zhao, Y., and White, M.A. (2007).
Broad spectrum identification of SUMO substrates in melanoma cells. Proteo-
mics 7, 2216–2221.
Geiss-Friedlander, R., and Melchior, F. (2007). Concepts in sumoylation:
a decade on. Nat. Rev. Mol. Cell Biol. 8, 947–956.
Gill, G. (2005). Something about SUMO inhibits transcription. Curr. Opin.
Genet. Dev. 15, 536–541.
Hannappel, E. (2007). beta-Thymosins. Ann. N Y Acad. Sci. 1112, 21–37.
Hapiak, V., Hresko, M.C., Schriefer, L.A., Saiyasisongkhram, K., Bercher, M.,
and Plenefisch, J. (2003).mua-6, a gene required for tissue integrity in Caeno-
rhabditis elegans, encodes a cytoplasmic intermediate filament. Dev. Biol.
263, 330–342.
Hay, R.T. (2005). SUMO: a history of modification. Mol. Cell 18, 1–12.
Herrmann, H., and Aebi, U. (2004). Intermediate filaments: molecular structure,
assembly mechanism, and integration into functionally distinct intracellular
Scaffolds. Annu. Rev. Biochem. 73, 749–789.
Hresko, M.C., Schriefer, L.A., Shrimankar, P., and Waterston, R.H. (1999).
Myotactin, a novel hypodermal protein involved in muscle-cell adhesion in
Caenorhabditis elegans. J. Cell Biol. 146, 659–672.
Jaitovich, A., Mehta, S., Na, N., Ciechanover, A., Goldman, R.D., and Ridge,
K.M. (2008). Ubiquitin-proteasome-mediated degradation of keratin interme-
diate filaments in mechanically stimulated A549 cells. J. Biol. Chem. 283,
25348–25355.
Johnson, E.S. (2004). Protein modification by SUMO. Annu. Rev. Biochem. 73,
355–382.
Johnson, E.S., and Blobel, G. (1999). Cell cycle-regulated attachment of
the ubiquitin-related protein SUMO to the yeast septins. J. Cell Biol. 147,
981–994.
Jones, D., Crowe, E., Stevens, T.A., and Candido, E.P. (2002). Functional and
phylogenetic analysis of the ubiquitylation system in Caenorhabditis elegans:
ubiquitin-conjugating enzymes, ubiquitin-activating enzymes, and ubiquitin-
like proteins. Genome Biol. 3, RESEARCH0002.
Karabinos, A., Schmidt, H., Harborth, J., Schnabel, R., and Weber, K. (2001).
Essential roles for four cytoplasmic intermediate filament proteins in
Caenorhabditis elegans development. Proc. Natl. Acad. Sci. USA 98, 7863–
7868.734 Developmental Cell 17, 724–735, November 17, 2009 ª2009 ElsKarabinos, A., Schulze, E., Schunemann, J., Parry, D.A., andWeber, K. (2003).
In vivo and in vitro evidence that the four essential intermediate filament (IF)
proteins A1, A2, A3 and B1 of the nematode Caenorhabditis elegans form an
obligate heteropolymeric IF system. J. Mol. Biol. 333, 307–319.
Kim, S., and Coulombe, P.A. (2007). Intermediate filament scaffolds fulfill
mechanical, organizational, and signaling functions in the cytoplasm. Genes
Dev. 21, 1581–1597.
Krimm, I., Ostlund, C., Gilquin, B., Couprie, J., Hossenlopp, P., Mornon, J.P.,
Bonne, G., Courvalin, J.C., Worman, H.J., and Zinn-Justin, S. (2002). The
Ig-like structure of the C-terminal domain of lamin A/C, mutated in muscular
dystrophies, cardiomyopathy, and partial lipodystrophy. Structure 10,
811–823.
Ku, N.-O., and Omary, M.B. (2000). Keratins turn over by ubiquitination in
a phosphorylation-modulated fashion. J. Cell Biol. 149, 547–552.
Ku, N.O., and Omary, M.B. (2001). Effect of mutation and phosphorylation of
type I keratins on their caspase-mediated degradation. J. Biol. Chem. 276,
26792–26798.
Liu, J., Rolef Ben-Shahar, T., Riemer, D., Treinin, M., Spann, P., Weber, K.,
Fire, A., and Gruenbaum, Y. (2000). Essential roles for Caenorhabditis elegans
lamin gene in nuclear organization, cell cycle progression, and spatial organi-
zation of nuclear pore complexes. Mol. Biol. Cell 11, 3937–3947.
Lu, H., Hesse, M., Peters, B., and Magin, T.M. (2005). Type II keratins precede
type I keratins during early embryonic development. Eur. J. Cell Biol. 84,
709–718.
Makhnevych, T., Sydorskyy, Y., Xin, X., Srikumar, T., Vizeacoumar, F.J.,
Jeram, S.M., Li, Z., Bahr, S., Andrews, B.J., Boone, C., and Raught, B.
(2009). Global map of SUMO function revealed by protein-protein interaction
and genetic networks. Mol. Cell 33, 124–135.
Melchior, F. (2000). SUMO—nonclassical ubiquitin. Annu. Rev. Cell Dev. Biol.
16, 591–626.
Nam-On Ku, Strnad, P., Zhong, B.H., Tao, G.Z., andOmary, M.B. (2007). Kera-
tins let liver live: mutations predispose to liver disease and crosslinking gener-
ates Mallory-Denk bodies. Hepatology 46, 1639–1649.
Nie, M., Xie, Y., Loo, J.A., and Courey, A.J. (2009). Genetic and proteomic
evidence for roles of Drosophila SUMO in cell cycle control, Ras signaling,
and early pattern formation. PLoS ONE 4, e5905.
Omary, M.B., Ku, N.-O., Tao, G.-Z., Toivola, D.M., and Liao, J. (2006). ‘Heads
and tails’ of intermediate filament phosphorylation: multiple sites and
functional insights. Trends Biochem. Sci. 31, 383–394.
Panse, V.G., Hardeland, U., Werner, T., Kuster, B., and Hurt, E. (2004).
A proteome-wide approach identifies sumoylated substrate proteins in yeast.
J. Biol. Chem. 279, 41346–41351.
Perry, J.J.P., Tainer, J.A., and Boddy, M.N. (2008). A SIM-ultaneous role for
SUMO and ubiquitin. Trends Biochem. Sci. 33, 201–208.
Plenefisch, J.D., Zhu, X., and Hedgecock, E.M. (2000). Fragile skeletal muscle
attachments in dystrophic mutants of Caenorhabditis elegans: isolation and
characterization of the mua genes. Development 127, 1197–1207.
Quinlan, R.A., Brenner, M., Goldman, J.E., and Messing, A. (2007). GFAP and
its role in Alexander disease. Exp. Cell Res. 313, 2077–2087.
Rosas-Acosta, G., Russell, W.K., Deyrieux, A., Russell, D.H., and Wilson, V.G.
(2005). A universal strategy for proteomic studies of SUMOand other ubiquitin-
like modifiers. Mol. Cell. Proteomics 4, 56–72.
Seeler, J.-S., and Dejean, A. (2003). Nuclear and unclear functions of SUMO.
Nat. Rev. Mol. Cell Biol. 4, 690–699.
Shumaker, D.K., Lopez-Soler, R.I., Adam, S.A., Herrmann, H., Moir, R.D.,
Spann, T.P., and Goldman, R.D. (2005). Functions and dysfunctions of the
nuclear lamin Ig-fold domain in nuclear assembly, growth, and Emery-Dreifuss
muscular dystrophy. Proc. Natl. Acad. Sci. USA 102, 15494–15499.
Shumaker, D.K., Solimando, L., Sengupta, K., Shimi, T., Adam, S.A., Grun-
wald, A., Strelkov, S.V., Aebi, U., Cardoso, M.C., and Goldman, R.D. (2008).
The highly conserved nuclear lamin Ig-fold binds to PCNA: its role in DNA repli-
cation. J. Cell Biol. 181, 269–280.evier Inc.
Developmental Cell
SUMO Regulates Cytoplasmic Intermediate FilamentsSong, J., Durrin, L.K., Wilkinson, T.A., Krontiris, T.G., and Chen, Y. (2004).
Identification of a SUMO-binding motif that recognizes SUMO-modified
proteins. Proc. Natl. Acad. Sci. USA 101, 14373–14378.
Sprague, B.L., and McNally, J.G. (2005). FRAP analysis of binding: proper
and fitting. Trends Cell Biol. 15, 84–91.
Takahashi, Y., Iwase, M., Konishi, M., Tanaka, M., Toh-e, A., and Kikuchi, Y.
(1999). Smt3, a SUMO-1 homolog, is conjugated to Cdc3, a component of
septin rings at the mother-bud neck in budding yeast. Biochem. Biophys.
Res. Commun. 259, 582–587.
Treier, M., Staszewski, L.M., and Bohmann, D. (1994). Ubiquitin-dependent
c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787–798.
Wohlschlegel, J.A., Johnson, E.S., Reed, S.I., and Yates, J.R., III. (2004).
Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol.
Chem. 279, 45662–45668.DevelopmWoo, W.M., Goncharov, A., Jin, Y., and Chisholm, A.D. (2004). Intermediate
filaments are required for C. elegans epidermal elongation. Dev. Biol. 267,
216–229.
Xue, Y., Zhou, F., Fu, C., Xu, Y., and Yao, X. (2006). SUMOsp: a web server
for sumoylation site prediction. Nucleic Acids Res. 34, W254–W257.
Yoon, K.H., Yoon, M., Moir, R.D., Khuon, S., Flitney, F.W., and Goldman, R.D.
(2001). Insights into the dynamic properties of keratin intermediate filaments in
living epithelial cells. J. Cell Biol. 153, 503–516.
Zhang, Y.-Q., and Sarge, K.D. (2008a). Sumoylation regulates lamin A function
and is lost in lamin Amutants associatedwith familial cardiomyopathies. J. Cell
Biol. 182, 35–39.
Zhang, Y.Q., and Sarge, K.D. (2008b). Sumoylation of amyloid precursor
protein negatively regulates Abeta aggregate levels. Biochem. Biophys. Res.
Commun. 374, 673–678.ental Cell 17, 724–735, November 17, 2009 ª2009 Elsevier Inc. 735
